Surgery Historical Income Statement

SGRY Stock

USD 24.02 0.17 0.70%

Historical analysis of Surgery Partners income statement accounts such as Gross Profit of 421.4 M, Other Operating Expenses of 1.5 B, Operating Income of 216.1 M or Ebit of 219 M can show how well Surgery Partners performed in making a profits. Evaluating Surgery Partners income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Surgery Partners's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Surgery Partners latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Surgery Partners is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgery Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

About Surgery Income Statement Analysis

Surgery Partners Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Surgery Partners shareholders. The income statement also shows Surgery investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Surgery Partners Income Statement Chart

At this time, Surgery Partners' Selling General Administrative is fairly stable compared to the past year. Total Operating Expenses is likely to rise to about 520.6 M in 2025, whereas Depreciation And Amortization is likely to drop slightly above 87.3 M in 2025.

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses

Total Revenue

Total revenue comprises all receipts Surgery Partners generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Surgery Partners minus its cost of goods sold. It is profit before Surgery Partners operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Surgery Partners. It is also known as Surgery Partners overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Surgery Partners' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Surgery Partners current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgery Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.At this time, Surgery Partners' Selling General Administrative is fairly stable compared to the past year. Total Operating Expenses is likely to rise to about 520.6 M in 2025, whereas Depreciation And Amortization is likely to drop slightly above 87.3 M in 2025.

	2022	2023	2024	2025 (projected)
Interest Expense	234.9M	193M	201.7M	154.1M
Depreciation And Amortization	149.6M	118.1M	152.6M	87.3M

Interest Expense Depreciation And Amortization

Surgery Partners income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Minority Interest	Net Income From Continuing Ops	Non Recurring	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items
Depreciation And Amortization		0.97	0.51	0.95	0.91	0.94	0.93	0.84	0.93	0.96	0.66	0.47	-0.87	0.03	0.31	-0.12	0.47	-0.24	0.74	0.97	-0.95	0.89	0.39
Interest Expense	0.97		0.45	0.95	0.91	0.94	0.91	0.86	0.93	0.95	0.63	0.4	-0.89	0.02	0.23	0.02	0.52	-0.14	0.76	0.92	-0.92	0.81	0.29
Selling General Administrative	0.51	0.45		0.57	0.6	0.59	0.51	0.53	0.55	0.56	0.94	0.6	-0.49	-0.6	0.74	-0.32	0.07	-0.34	0.77	0.51	-0.56	0.74	0.92
Total Revenue	0.95	0.95	0.57		0.99	1.0	0.93	0.94	0.98	1.0	0.76	0.52	-0.83	-0.15	0.36	-0.05	0.5	-0.19	0.82	0.93	-0.88	0.9	0.47
Gross Profit	0.91	0.91	0.6	0.99		0.99	0.92	0.95	0.97	0.99	0.79	0.55	-0.8	-0.18	0.36	-0.06	0.53	-0.23	0.82	0.89	-0.84	0.9	0.52
Other Operating Expenses	0.94	0.94	0.59	1.0	0.99		0.92	0.94	0.98	1.0	0.77	0.53	-0.82	-0.17	0.38	-0.06	0.48	-0.2	0.82	0.93	-0.88	0.91	0.5
Operating Income	0.93	0.91	0.51	0.93	0.92	0.92		0.84	0.9	0.93	0.69	0.64	-0.76	0.15	0.26	-0.2	0.72	-0.47	0.72	0.87	-0.87	0.87	0.4
Ebit	0.84	0.86	0.53	0.94	0.95	0.94	0.84		0.98	0.94	0.73	0.61	-0.69	-0.21	0.5	0.05	0.44	-0.14	0.86	0.84	-0.79	0.81	0.43
Ebitda	0.93	0.93	0.55	0.98	0.97	0.98	0.9	0.98		0.98	0.73	0.58	-0.78	-0.13	0.45	-0.01	0.47	-0.18	0.85	0.92	-0.88	0.87	0.43
Cost Of Revenue	0.96	0.95	0.56	1.0	0.99	1.0	0.93	0.94	0.98		0.75	0.51	-0.84	-0.14	0.36	-0.04	0.49	-0.18	0.82	0.94	-0.89	0.9	0.45
Total Operating Expenses	0.66	0.63	0.94	0.76	0.79	0.77	0.69	0.73	0.73	0.75		0.68	-0.62	-0.51	0.67	-0.26	0.29	-0.37	0.85	0.65	-0.7	0.84	0.82
Income Before Tax	0.47	0.4	0.6	0.52	0.55	0.53	0.64	0.61	0.58	0.51	0.68		-0.19	0.01	0.7	-0.4	0.5	-0.73	0.64	0.44	-0.53	0.63	0.52
Total Other Income Expense Net	-0.87	-0.89	-0.49	-0.83	-0.8	-0.82	-0.76	-0.69	-0.78	-0.84	-0.62	-0.19		0.07	-0.1	0.12	-0.36	0.07	-0.57	-0.85	0.88	-0.79	-0.32
Net Income	0.03	0.02	-0.6	-0.15	-0.18	-0.17	0.15	-0.21	-0.13	-0.14	-0.51	0.01	0.07		-0.55	-0.08	0.54	-0.39	-0.42	-0.05	-0.01	-0.2	-0.61
Income Tax Expense	0.31	0.23	0.74	0.36	0.36	0.38	0.26	0.5	0.45	0.36	0.67	0.7	-0.1	-0.55		-0.23	-0.2	-0.24	0.69	0.36	-0.4	0.52	0.7
Minority Interest	-0.12	0.02	-0.32	-0.05	-0.06	-0.06	-0.2	0.05	-0.01	-0.04	-0.26	-0.4	0.12	-0.08	-0.23		-0.1	0.61	0.1	-0.11	0.25	-0.42	-0.36
Net Income From Continuing Ops	0.47	0.52	0.07	0.5	0.53	0.48	0.72	0.44	0.47	0.49	0.29	0.5	-0.36	0.54	-0.2	-0.1		-0.61	0.29	0.34	-0.42	0.37	-0.04
Non Recurring	-0.24	-0.14	-0.34	-0.19	-0.23	-0.2	-0.47	-0.14	-0.18	-0.18	-0.37	-0.73	0.07	-0.39	-0.24	0.61	-0.61		-0.12	-0.18	0.29	-0.41	-0.34
Tax Provision	0.74	0.76	0.77	0.82	0.82	0.82	0.72	0.86	0.85	0.82	0.85	0.64	-0.57	-0.42	0.69	0.1	0.29	-0.12		0.71	-0.73	0.73	0.61
Interest Income	0.97	0.92	0.51	0.93	0.89	0.93	0.87	0.84	0.92	0.94	0.65	0.44	-0.85	-0.05	0.36	-0.11	0.34	-0.18	0.71		-0.92	0.9	0.43
Net Interest Income	-0.95	-0.92	-0.56	-0.88	-0.84	-0.88	-0.87	-0.79	-0.88	-0.89	-0.7	-0.53	0.88	-0.01	-0.4	0.25	-0.42	0.29	-0.73	-0.92		-0.89	-0.37
Reconciled Depreciation	0.89	0.81	0.74	0.9	0.9	0.91	0.87	0.81	0.87	0.9	0.84	0.63	-0.79	-0.2	0.52	-0.42	0.37	-0.41	0.73	0.9	-0.89		0.68
Extraordinary Items	0.39	0.29	0.92	0.47	0.52	0.5	0.4	0.43	0.43	0.45	0.82	0.52	-0.32	-0.61	0.7	-0.36	-0.04	-0.34	0.61	0.43	-0.37	0.68

Click cells to compare fundamentals

Surgery Partners Account Relationship Matchups

Surgery Partners income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	134.2M	137.9M	149.6M	118.1M	152.6M	87.3M
Interest Expense	201.8M	221M	234.9M	193M	201.7M	154.1M
Selling General Administrative	97.1M	104M	102.2M	120.9M	495.8M	520.6M
Total Revenue	1.9B	2.2B	2.5B	2.7B	3.1B	1.7B
Gross Profit	379.8M	491.4M	574.9M	647.5M	745.6M	421.4M
Other Operating Expenses	1.6B	1.9B	2.2B	2.4B	2.9B	1.5B
Operating Income	246.6M	302.2M	345.2M	328M	348.8M	216.1M
Ebit	143.6M	263.1M	310.4M	328M	348.8M	219.0M
Ebitda	277.8M	401M	460M	446.1M	501.4M	306.3M
Cost Of Revenue	1.5B	1.7B	2.0B	2.1B	2.4B	1.3B
Total Operating Expenses	145.7M	164.9M	214.6M	319.5M	495.8M	520.6M
Income Before Tax	(18.8M)	81.2M	110.3M	135M	147.1M	154.5M
Total Other Income Expense Net	(201.8M)	(221M)	(234.9M)	(193M)	(201.7M)	(191.6M)
Net Income	1.3M	70.7M	87M	(11.9M)	(168.1M)	(159.7M)
Income Tax Expense	(20.1M)	10.5M	23.3M	300K	134.6M	141.3M
Minority Interest	117.4M	(141.6M)	141.6M	(146.2M)	(180.6M)	(171.6M)
Net Income From Continuing Ops	1.3M	70.7M	87M	111.9M	12.5M	11.9M
Non Recurring	25.7M	56.2M	24.3M	1.6M	1.4M	1.4M
Net Income Applicable To Common Shares	(110.5M)	(155.6M)	(81.2M)	(54.6M)	(49.1M)	(51.6M)
Tax Provision	(20.1M)	10.5M	23.3M	3.6M	134.6M	141.3M
Net Interest Income	(201.8M)	(221M)	(234.9M)	(205.3M)	(201.7M)	(211.8M)
Reconciled Depreciation	94.8M	98.8M	114.8M	116.6M	152.6M	106.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Surgery Historical Income Statement

About Surgery Income Statement Analysis

Surgery Partners Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Surgery Partners income statement Correlations

Surgery Partners Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Surgery Partners income statement Accounts

Also Currently Popular

Additional Tools for Surgery Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Other Operating Expenses
Gross Profit	+ 0.99	Total Revenue
Other Operating Expenses	+ 0.99	Gross Profit
Cost Of Revenue	+ 0.99	Gross Profit

Net Interest Income	- 0.95	Depreciation And Amortization
Net Interest Income	- 0.92	Interest Income
Net Interest Income	- 0.92	Interest Expense
Reconciled Depreciation	- 0.89	Net Interest Income
Net Interest Income	- 0.89	Cost Of Revenue
Total Other Income Expense Net	- 0.89	Interest Expense